DE2527907A1 - Pharmazeutische oder veterinaermedizinische zusammensetzungen auf der grundlage von acetoximderivaten - Google Patents

Pharmazeutische oder veterinaermedizinische zusammensetzungen auf der grundlage von acetoximderivaten

Info

Publication number
DE2527907A1
DE2527907A1 DE19752527907 DE2527907A DE2527907A1 DE 2527907 A1 DE2527907 A1 DE 2527907A1 DE 19752527907 DE19752527907 DE 19752527907 DE 2527907 A DE2527907 A DE 2527907A DE 2527907 A1 DE2527907 A1 DE 2527907A1
Authority
DE
Germany
Prior art keywords
animals
compound
dose
compounds
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19752527907
Other languages
German (de)
English (en)
Inventor
Jean-Louis Alain Benoit-Guyod
Andre Louis Boucherle
Madeleine Broll
Pierre Luc Eymard
Georges Marcel Taillandier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labaz SA
Original Assignee
Labaz SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz SA filed Critical Labaz SA
Publication of DE2527907A1 publication Critical patent/DE2527907A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE19752527907 1974-06-25 1975-06-23 Pharmazeutische oder veterinaermedizinische zusammensetzungen auf der grundlage von acetoximderivaten Ceased DE2527907A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7422033A FR2276033A1 (fr) 1974-06-25 1974-06-25 Derives actifs d'acetoxime, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions

Publications (1)

Publication Number Publication Date
DE2527907A1 true DE2527907A1 (de) 1976-01-08

Family

ID=9140483

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752527907 Ceased DE2527907A1 (de) 1974-06-25 1975-06-23 Pharmazeutische oder veterinaermedizinische zusammensetzungen auf der grundlage von acetoximderivaten

Country Status (21)

Country Link
US (1) US4032660A (enExample)
JP (1) JPS5756912B2 (enExample)
AR (1) AR207467A1 (enExample)
AT (1) AT341489B (enExample)
BE (1) BE830576A (enExample)
CA (1) CA1032871A (enExample)
CH (1) CH596155A5 (enExample)
DE (1) DE2527907A1 (enExample)
DK (1) DK144761C (enExample)
ES (1) ES438861A1 (enExample)
FI (1) FI61689C (enExample)
FR (1) FR2276033A1 (enExample)
GB (1) GB1453921A (enExample)
IE (1) IE41623B1 (enExample)
IT (1) IT1044296B (enExample)
NL (1) NL7505205A (enExample)
NO (1) NO140298C (enExample)
OA (1) OA05037A (enExample)
SE (1) SE422054B (enExample)
YU (1) YU36696B (enExample)
ZA (1) ZA753348B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362408A (en) * 1992-07-14 1994-11-08 The Western Company Of North America High temperature gel stabilizer for fracturing fluids

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237069A (en) * 1979-07-02 1980-12-02 Allied Chemical Corporation Production of alpha-hydroxy oximes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3224873A (en) * 1963-02-25 1965-12-21 Gen Mills Inc Liquid-liquid recovery of copper values using alpha-hydroxy oximes
US3346523A (en) * 1964-08-03 1967-10-10 Exxon Research Engineering Co Coating compositions made from oximes
US3437454A (en) * 1966-04-26 1969-04-08 Kerr Mc Gee Chem Corp Vanadium recovery from wet process phosphoric acid using alpha-hydroxy oximes
US3794719A (en) * 1972-02-25 1974-02-26 Sec Corp Reduction of nickel contamination by zinc in {60 -hydroxy oxime extract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362408A (en) * 1992-07-14 1994-11-08 The Western Company Of North America High temperature gel stabilizer for fracturing fluids

Also Published As

Publication number Publication date
AU8163875A (en) 1976-12-02
AR207467A1 (es) 1976-10-08
ATA487475A (de) 1977-06-15
NO140298B (no) 1979-04-30
FI751603A7 (enExample) 1975-12-26
YU36696B (en) 1984-08-31
FI61689B (fi) 1982-05-31
FR2276033B1 (enExample) 1978-07-21
SE422054B (sv) 1982-02-15
JPS5756912B2 (enExample) 1982-12-02
AT341489B (de) 1978-02-10
IE41623L (en) 1975-12-25
CH596155A5 (enExample) 1978-02-28
DK144761B (da) 1982-06-01
DK285175A (da) 1975-12-26
FR2276033A1 (fr) 1976-01-23
DK144761C (da) 1982-10-25
YU122575A (en) 1982-06-18
NO752241L (enExample) 1975-12-30
NL7505205A (nl) 1975-12-30
IT1044296B (it) 1980-03-20
ZA753348B (en) 1976-05-26
US4032660A (en) 1977-06-28
GB1453921A (en) 1976-10-27
JPS5123213A (enExample) 1976-02-24
NO140298C (no) 1979-08-08
ES438861A1 (es) 1977-05-16
OA05037A (fr) 1980-12-31
SE7507253L (sv) 1975-12-29
BE830576A (fr) 1975-12-24
IE41623B1 (en) 1980-02-13
FI61689C (fi) 1982-09-10
CA1032871A (en) 1978-06-13

Similar Documents

Publication Publication Date Title
DE3019350C2 (enExample)
DE1620608B2 (de) N-substltuierte Lactame und Verfahren zu ihrer Herstellung
DE2163911B2 (de) 2-Aminomethyl-phenole, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel
DE2800954A1 (de) Derivate des meta-trifluoromethylphenylpiperazins und deren verwendung als arzneimittel
DE2438399C3 (de) a-substituierte Benzhydrolderivate und ihre Salze, solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben
DE2719607C2 (enExample)
DE602004006633T2 (de) Verwendung von dapson als neuroprotektor bei zerebralinfarkt
DE2749520A1 (de) Harnstoffderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische und veterinaermedizinische zusammensetzungen
DE2633891C2 (de) Tris-(hydroxymethyl)-aminomethansalz der 2-(5-Benzoylthienyl)-&amp;alpha;-methylessigsäure, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen
DE2163054A1 (de) Lokalanaesthetisches mittel
DE3611427A1 (de) Bis-tertiaerbutylamino-substituierte 1,3,5-triazinderivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
DE2755017C2 (enExample)
DE2530515C2 (de) 4- bzw. 7-Hydroxy-4,5,6,7-tetrahydrothieno-[3,2-c] bzw.[2,3-c] pyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittelzubereitungen
DE2501649C3 (de) Thiophen-2-carbonsäuresalz des Papaverins, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2916880C2 (de) Arzneimittel mit sedativer und schlafinduzierender Wirkung
DE2437272B2 (de) 6-Trifluormethyl-2H-1,2,4-benzothiadiazin-l,l-dioxyde und sie enthaltende Arzneimittelzubereitungen
DE60012183T2 (de) Verwendung einer makrolid-verbindung zur herstellung eines medikaments zur behandlung von gehirnschäden aufgrund von ischämie oder blutungen
DE2502684C2 (enExample)
DE2110537C3 (de) N-Pyridyl-brenzschleimsäureamide, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2648830B2 (de) 2-Pyrrolidon-5-carbonsäuresalz des Kreatinin!, Verfahren zu dessen Herstellung und dieses enthaltendes pharmazeutisches Mittel
DE69417724T2 (de) 5-Morpholinmethyl-3-(4-chlorbenzylidenamin)-2-oxazolidinon enthaltende pharmazeutische Zubereitung und ihre Verwendung zur Behandlung von Erkrankungen des ZNS
DE2166662B2 (de) Dibenzothiazepinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE3239719T1 (de) Uracil-Derivate, Verfahren zu ihrer Herstellung und dieselben enthaltende pharmazeutische Zusammensetzungen
DE3237438C2 (de) 2-Thiazolamin-Derivate und dieselben enthaltende pharmazeutische Zusammensetzungen
AT335469B (de) Verfahren zur herstellung des neuen 4-(n-propyl)-n-heptanol-3-carbamates

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection